Perspective Therapeutics, Inc. (CATX)
2.815
+0.04
(+1.62%)
USD |
NYAM |
Sep 11, 14:42
Perspective Therapeutics Gross Profit (TTM) : -3.644M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.644M |
| March 31, 2026 | -3.027M |
| December 31, 2025 | -2.367M |
| September 30, 2025 | -1.874M |
| June 30, 2025 | -1.608M |
| March 31, 2025 | -1.211M |
| December 31, 2024 | -0.852M |
| September 30, 2024 | -0.31M |
| June 30, 2024 | 0.315M |
| March 31, 2024 | 0.395M |
| September 30, 2023 | 1.352M |
| June 30, 2023 | 2.726M |
| March 31, 2023 | 3.621M |
| June 30, 2022 | 4.616M |
| March 31, 2022 | 5.036M |
| December 31, 2021 | 4.957M |
| September 30, 2021 | 4.904M |
| June 30, 2021 | 5.121M |
| March 31, 2021 | 4.846M |
| December 31, 2020 | 5.19M |
| September 30, 2020 | 5.134M |
| June 30, 2020 | 5.124M |
| March 31, 2020 | 4.932M |
| December 31, 2019 | 4.105M |
| September 30, 2019 | 3.759M |
| Date | Value |
|---|---|
| June 30, 2019 | 3.047M |
| March 31, 2019 | 2.605M |
| December 31, 2018 | 2.335M |
| September 30, 2018 | 2.101M |
| June 30, 2018 | 1.842M |
| March 31, 2018 | 1.903M |
| December 31, 2017 | 1.587M |
| September 30, 2017 | 1.055M |
| June 30, 2017 | 0.838M |
| March 31, 2017 | 0.2925M |
| December 31, 2016 | 0.0658M |
| September 30, 2016 | 0.0937M |
| June 30, 2016 | 0.1292M |
| March 31, 2016 | 0.3816M |
| December 31, 2015 | 0.3676M |
| September 30, 2015 | 0.3027M |
| June 30, 2015 | 0.1644M |
| March 31, 2015 | -0.1767M |
| December 31, 2014 | -0.178M |
| September 30, 2014 | -0.174M |
| June 30, 2014 | -0.1965M |
| March 31, 2014 | 0.083M |
| December 31, 2013 | 0.218M |
| September 30, 2013 | 0.0933M |
| June 30, 2013 | 0.1502M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Anika Therapeutics, Inc. | 75.00M |
| MiMedx Group, Inc. | 279.22M |
| ABVC BioPharma, Inc. | -0.4917M |
| Enovis Corp. | 1.225B |
| Edwards Lifesciences Corp. | 5.098B |